Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”
by Amanda Rose Ferraro
Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.
by Marci A. Landsmann
FROM THE EDITOR-IN-CHIEF
Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.
by William G. Nelson, MD, PhD
Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.
by Kendall K. Morgan
Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.
by Kate Yandell
Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
by Lindsey Konkel
After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank.
by Jen Tota McGivney
Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.
The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.
Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.
Follow My Lead
donate to the AACR